Cummings M - Search Results

1

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.

Farshid G, Balleine RL, Cummings M, Waring P; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab). Farshid G, et al. Among authors: cummings m. Am J Surg Pathol. 2006 Nov;30(11):1357-66. doi: 10.1097/01.pas.0000213273.22844.1a. Am J Surg Pathol. 2006. PMID: 17063074

2

Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis.

Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG, McGuckin MA. Cummings MC, et al. Am J Surg Pathol. 2002 Oct;26(10):1286-95. doi: 10.1097/00000478-200210000-00005. Am J Surg Pathol. 2002. PMID: 12360043

3

Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.

Chenevix-Trench G, Healey S, Lakhani S, Waring P, Cummings M, Brinkworth R, Deffenbaugh AM, Burbidge LA, Pruss D, Judkins T, Scholl T, Bekessy A, Marsh A, Lovelock P, Wong M, Tesoriero A, Renard H, Southey M, Hopper JL, Yannoukakos K, Brown M, Easton D, Tavtigian SV, Goldgar D, Spurdle AB; kConFab Investigators. Chenevix-Trench G, et al. Among authors: cummings m. Cancer Res. 2006 Feb 15;66(4):2019-27. doi: 10.1158/0008-5472.CAN-05-3546. Cancer Res. 2006. PMID: 16489001

4

Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry.

Bilous M, Morey A, Armes J, Cummings M, Francis G. Bilous M, et al. Among authors: cummings m. Pathology. 2006 Apr;38(2):120-4. doi: 10.1080/00313020600561518. Pathology. 2006. PMID: 16581651

5

Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.

Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC; Australian Cancer Study Group; Australian Ovarian Cancer Study Group. Nagle CM, et al. Eur J Cancer. 2008 Nov;44(16):2477-84. doi: 10.1016/j.ejca.2008.07.009. Epub 2008 Aug 15. Eur J Cancer. 2008. PMID: 18707869

6

Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.

Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; Australian Ovarian Cancer Study Management Group. Lose F, et al. J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28. J Natl Cancer Inst. 2008. PMID: 18957670

7

HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer.

Da Silva L, Simpson PT, Smart CE, Cocciardi S, Waddell N, Lane A, Morrison BJ, Vargas AC, Healey S, Beesley J, Pakkiri P, Parry S, Kurniawan N, Reid L, Keith P, Faria P, Pereira E, Skalova A, Bilous M, Balleine RL, Do H, Dobrovic A, Fox S, Franco M, Reynolds B, Khanna KK, Cummings M, Chenevix-Trench G, Lakhani SR. Da Silva L, et al. Among authors: cummings m. Breast Cancer Res. 2010;12(4):R46. doi: 10.1186/bcr2603. Epub 2010 Jul 6. Breast Cancer Res. 2010. PMID: 20604919 Free PMC article.

8

Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families.

Balleine RL, Provan PJ, Pupo GM, Pathmanathan N, Cummings M, Farshid G, Salisbury EL, Bilous AM, Byth K; KConFab Investigators; Mann GJ. Balleine RL, et al. Among authors: cummings m. Genes Chromosomes Cancer. 2010 Dec;49(12):1082-94. doi: 10.1002/gcc.20816. Genes Chromosomes Cancer. 2010. PMID: 20815029

9

Establishment of the Australian in situ hybridization program for the assessment of HER2 amplification in breast cancer: a model for the introduction of new biomarkers into clinical practice.

Farshid G, Armes JE, Bell R, Cummings M, Fox S, Francis G, Haswell M, Morey A, McCue G, Raymond W, Robbins P, Bilous M. Farshid G, et al. Among authors: cummings m. Diagn Mol Pathol. 2010 Dec;19(4):187-93. doi: 10.1097/PDM.0b013e3181e1cc9d. Diagn Mol Pathol. 2010. PMID: 21052003

10

Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations.

George J, Alsop K, Etemadmoghadam D, Hondow H, Mikeska T, Dobrovic A, deFazio A; Australian Ovarian Cancer Study Group; Smyth GK, Levine DA, Mitchell G, Bowtell DD. George J, et al. Clin Cancer Res. 2013 Jul 1;19(13):3474-84. doi: 10.1158/1078-0432.CCR-13-0066. Epub 2013 Apr 30. Clin Cancer Res. 2013. PMID: 23633455

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,087 results

Search Page

Filters